These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6448165)

  • 1. Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons.
    Waldmeier PC
    Experientia; 1980 Sep; 36(9):1092-4. PubMed ID: 6448165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the activation of dopamine metabolism by a serotonin uptake inhibitor.
    Waldmeier PC
    Eur J Pharmacol; 1979 Dec; 60(4):315-22. PubMed ID: 527667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M; Sjöholm B; Lappalainen J; Virtanen R
    Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of dopamine synthesis in mesolimbic dopamine neurons by immobilization stress in the rat.
    Watanabe H
    Neuropharmacology; 1984 Nov; 23(11):1335-8. PubMed ID: 6441893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M; Mataga N; Takashima M; Nishikawa T
    Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.
    Deutch AY; Tam SY; Freeman AS; Bowers MB; Roth RH
    Eur J Pharmacol; 1987 Feb; 134(3):257-64. PubMed ID: 3569414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of serotonin and dopamine metabolism in various forebrain areas of rats injected with morphine either systemically or in the raphe nuclei dorsalis and medianus.
    Spampinato U; Esposito E; Romandini S; Samanin R
    Brain Res; 1985 Feb; 328(1):89-95. PubMed ID: 2578858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC; Delini-Stula AA
    Eur J Pharmacol; 1979 May; 55(4):363-73. PubMed ID: 572774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.
    Kitaichi K; Yamada K; Hasegawa T; Furukawa H; Nabeshima T
    Jpn J Pharmacol; 1994 Oct; 66(2):181-9. PubMed ID: 7532732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA; Piercey MF
    J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of dopamine metabolism in rat brain frontal cortex: a common effect of chronically administered antipsychotic drugs.
    Mefford IN; Roth KA; Agren H; Barchas JD
    Brain Res; 1988 Dec; 475(2):380-4. PubMed ID: 2905626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of serotonin involvement in the effect of morphine on dopamine metabolism in the rat nucleus accumbens but not in the striatum.
    Spampinato U; Invernizzi R; Samanin R
    Pharmacol Res Commun; 1984 May; 16(5):519-23. PubMed ID: 6234602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aminooxyacetic acid and baclofen on the catalepsy and on the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats.
    Kääriäinen I
    Acta Pharmacol Toxicol (Copenh); 1976 Sep; 39(3):393-400. PubMed ID: 989685
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurochemical effects of chronic haloperidol and lithium assessed by brain microdialysis in rats.
    Hernandez L; Baptista T; Hoebel BG
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14 Suppl():S17-35. PubMed ID: 2097671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress and the mesocorticolimbic dopamine systems.
    Roth RH; Tam SY; Ida Y; Yang JX; Deutch AY
    Ann N Y Acad Sci; 1988; 537():138-47. PubMed ID: 3059920
    [No Abstract]   [Full Text] [Related]  

  • 16. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    J Pharm Pharmacol; 1978 Sep; 30(9):583-5. PubMed ID: 29101
    [No Abstract]   [Full Text] [Related]  

  • 17. On the relation between haloperidol-induced alterations in DA release and DA metabolism in rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    Life Sci; 1978 Aug; 23(6):611-5. PubMed ID: 692284
    [No Abstract]   [Full Text] [Related]  

  • 18. Clozapine: reduction of the initial dopamine turnover increase by repeated treatment.
    Waldmeier PC; Maître L
    Eur J Pharmacol; 1976 Jul; 38(1):197-203. PubMed ID: 954831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M
    Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
    Ladinsky H; Consolo S; Samanin R; Algeri S; Ponzio F
    Adv Biochem Psychopharmacol; 1980; 24():259-65. PubMed ID: 7405665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.